160 related articles for article (PubMed ID: 33622658)
1. Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL Amyloidosis.
Acevedo J; Doros G; Szalat R; Sanchorawala V
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):425-426. PubMed ID: 33622658
[No Abstract] [Full Text] [Related]
2. Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type.
Muchtar E; Dispenzieri A; Kumar SK; Buadi FK; Lacy MQ; Zeldenrust S; Hayman SR; Leung N; Chakraborty R; Russell S; Dingli D; Lust JA; Lin Y; Kapoor P; Go R; Kyle RA; Rajkumar VS; Gertz MA
Amyloid; 2017 Mar; 24(sup1):44-45. PubMed ID: 28434304
[No Abstract] [Full Text] [Related]
3. Conventional Therapy for Amyloid Light-Chain Amyloidosis.
Milani P; Palladini G
Acta Haematol; 2020; 143(4):365-372. PubMed ID: 32353854
[TBL] [Abstract][Full Text] [Related]
4. Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside.
Basset M; Nuvolone M; Palladini G; Merlini G
Expert Rev Hematol; 2020 Sep; 13(9):1003-1015. PubMed ID: 32721177
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and Staging of AL Amyloidosis.
Dittrich T; Kimmich C; Hegenbart U; Schönland SO
Acta Haematol; 2020; 143(4):388-400. PubMed ID: 32570242
[TBL] [Abstract][Full Text] [Related]
6. High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis.
Sanchorawala V
Acta Haematol; 2020; 143(4):381-387. PubMed ID: 32248194
[TBL] [Abstract][Full Text] [Related]
7. Systemic amyloidosis: moving into the spotlight.
Cohen OC; Wechalekar AD
Leukemia; 2020 May; 34(5):1215-1228. PubMed ID: 32269317
[TBL] [Abstract][Full Text] [Related]
8. Nonchemotherapy Treatment of Immunoglobulin Light Chain Amyloidosis.
Van Doren L; Lentzsch S
Acta Haematol; 2020; 143(4):373-380. PubMed ID: 32526750
[TBL] [Abstract][Full Text] [Related]
9. Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis.
Abeykoon JP; Paludo J; Dispenzieri A; Gertz MA; Dingli D; Baudi FK; Gonsalves WI; Kyle RA; Lacy MQ; Hayman SR; Leung N; Kourelis T; Rajkumar SV; Kumar S; Kapoor P
Amyloid; 2017 Mar; 24(sup1):50-51. PubMed ID: 28434368
[No Abstract] [Full Text] [Related]
10. Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation.
Sidiqi MH; Aljama MA; Jevremovic D; Morice WG; Timm M; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Gonsalves WI; Kumar S; Kapoor P; Kourelis T; Leung N; Hogan WJ; Gertz M
Haematologica; 2018 Jul; 103(7):1229-1234. PubMed ID: 29674497
[TBL] [Abstract][Full Text] [Related]
11. Localized Lymph Node Light Chain Amyloidosis.
Yamamoto A; Fujii N; Obika M; Yamashita T; Otsuka F
Intern Med; 2020 Oct; 59(19):2415-2418. PubMed ID: 32611959
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.
Sidana S; Tandon N; Dispenzieri A; Gertz MA; Buadi FK; Lacy MQ; Dingli D; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Hwa YL; Kapoor P; Kyle RA; Leung N; Go RS; Lust JA; Russell SJ; Zeldenrust SR; Rajkumar SV; Kumar SK
Leukemia; 2018 Mar; 32(3):729-735. PubMed ID: 28919633
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
14. Ascites in the Course of Plasma Cell Myeloma Complicated by AL Amyloidosis.
Debski J; Usnarska-Zubkiewicz L; Kapelko-Słowik K; Pawluś A; Zaleska-Dorobisz U; Kuliczkowski K
Turk J Haematol; 2018 Mar; 35(1):71-72. PubMed ID: 27531413
[No Abstract] [Full Text] [Related]
15. Autologous Hematopoietic Cell Transplantation Versus Chemotherapy Alone for Immunoglobulin Light Chain Amyloidosis: A Retrospective Study.
Miyazaki K; Suzuki K
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):413-422.e5. PubMed ID: 31023593
[TBL] [Abstract][Full Text] [Related]
16. Fibril-directed Therapies in Systemic Light Chain AL Amyloidosis.
Bhutani D; Leng S; Lentzsch S
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):555-559. PubMed ID: 31262668
[TBL] [Abstract][Full Text] [Related]
17. Supportive Care in AL Amyloidosis.
Cibeira MT; Ortiz-Pérez JT; Quintana LF; Fernádez de Larrea C; Tovar N; Bladé J
Acta Haematol; 2020; 143(4):335-342. PubMed ID: 32235118
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Light Chain Deposition Disease Mimicking Immunoglobulin Light Chain Amyloidosis: Two Branches of the Same Tree.
Osanami A; Yano T; Takemura G; Ikeda H; Inyaku M; Toda Y; Kamiyama N; Sugawara H; Gocho Y; Fujito T; Nagano N; Takahashi S; Muranaka A; Tanaka M; Moniwa N; Murase K; Takada K; Kuroda H; Ogawa Y; Miura T
Circ Cardiovasc Imaging; 2020 Sep; 13(9):e010478. PubMed ID: 32873072
[No Abstract] [Full Text] [Related]
19. [Primary amyloidosis].
González de la Calle V; García-Sanz R; Mateos MV
Med Clin (Barc); 2016 Aug; 147(3):121-6. PubMed ID: 27085744
[No Abstract] [Full Text] [Related]
20. Management of the elderly patient with AL amyloidosis.
Nuvolone M; Milani P; Palladini G; Merlini G
Eur J Intern Med; 2018 Dec; 58():48-56. PubMed ID: 29801808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
